What the Weight Regain Studies on Mounjaro Actually Show

What did the SURMOUNT-4 study find about regain after stopping Mounjaro?

SURMOUNT-4 was a randomised withdrawal trial. All participants first took tirzepatide for 36 weeks, achieving an average weight loss of around 20%. They were then split into two groups: one continued on the medicine, the other switched to placebo. After a further 52 weeks, those on placebo had regained around 14% of their body weight. Those who stayed on tirzepatide lost an additional 5.5%.

That gap (roughly 19 percentage points between the two groups at the end of the full trial) is striking. It's also consistent with what has been observed with semaglutide. The STEP 1 extension data, published in the New England Journal of Medicine, showed a similar pattern after semaglutide was withdrawn: the majority of weight lost returned within about a year.

The message from both trials is the same. These medicines work while they're being taken. When they stop, the mechanisms that regulate appetite and body weight revert. That's not a design flaw; it's what you'd expect from treating any chronic condition with medication.

Why does the weight come back when tirzepatide stops?

Tirzepatide activates GIP and GLP-1 receptors, which together reduce appetite, slow digestion and help the body feel full on less food. Stop the medicine, and those signals diminish. The body's own appetite hormones, which obesity research shows are persistently dysregulated in many people with higher body weight, reassert themselves.

This is why researchers and clinicians are increasingly framing obesity as a chronic condition that may need ongoing management, rather than something treated once and resolved. The NHS tirzepatide guidance, available on the NHS medicines page for tirzepatide, acknowledges this in how it discusses duration of treatment.

It also explains why the question of how to come off Mounjaro without undoing progress is one our prescribers hear regularly. The lifestyle changes built during treatment, diet quality, physical activity, sleep, matter more once the medicine is withdrawn. They don't fully compensate, but they slow regain and protect some of the benefit. There's more on the practical side of that on our page covering stopping Mounjaro without gaining weight.

Does this mean treatment has to be indefinite?

Not necessarily, though for many people long-term use is what the evidence supports. NICE's guidance on tirzepatide (TA1026) frames the medicine within a broader weight management programme. The question of whether to continue, pause or stop is a clinical one, made with your prescriber based on how much weight you've lost, how long you've been treated, your overall health picture and your own goals.

Some people do stop successfully, particularly those who have made substantial changes to their eating habits and activity levels during treatment. The regain data shows the average; individuals vary. What SURMOUNT-4 rules out is the assumption that a short course of tirzepatide delivers permanent change with no further input. For context on what a longer course looks like in practice, the weight regain after Mounjaro page goes into more detail on duration and management options.

For anyone reading this while weighing up the cost of continuing, our treatment overview page explains what's included in a private prescription through nume, including the clinical reviews that happen before every repeat order. Pricing context is available there too. The short answer on cost is that continuing on tirzepatide through a regulated pharmacy carries an ongoing monthly cost, and that's a real consideration, one worth discussing with a prescriber rather than making unilaterally.

What should someone do with this information?

If you're currently on Mounjaro and worried about stopping, the first step is a conversation with your prescriber rather than stopping unilaterally. Sudden withdrawal isn't medically dangerous, but it removes the treatment benefit without any managed plan for maintaining progress.

If you're considering starting and wondering whether it's worth it given the regain data, that's a reasonable question. The trials show substantial weight loss during treatment, with proven benefits for blood pressure, blood sugar and cardiovascular risk markers in many participants. If you want a fuller picture of whether you regain weight after stopping Mounjaro, including what the evidence says about individual variation, that page covers it in detail.

The data on tirzepatide and weight regain is now well-established enough to plan around. A prescriber can help you think through what a realistic treatment arc looks like for your situation, whether that's a defined course, ongoing treatment, or a structured withdrawal with a clear plan. Mounjaro is available only on prescription following a clinical assessment; a prescriber, not an algorithm, makes that call. You can read more about how Mounjaro works and how long it takes to show results before making any decisions.